#OurMaterTeam Dr Austin Duffy, Director of Research in START Dublin said: "Now that we have an early phase oncology clinical trials unit here in Dublin, we hope to offer patients access to new and promising drugs years before they might otherwise become available.”

#DYK #MaterHospital is the only centre to offer curative resection of all extracranial sites of metastatic disease, including Hyperthermic Intraperitoneal Chemotherapy to patients with advanced colorectal, peritoneal and appendiceal cancer, and women with ovarian cancer?.

It was great to see such a turn out for @TheMaterFoundat Marilyn's Mater Paddle on Sunday. A huge thank you to all involved.

Advanced cancer can mean many things and can also be called secondary cancer, late stage cancer, locally advanced cancer, metastatic cancer, stage 4 cancer, recurrent cancer or complex cancer.

RT @MaterTrauma: Ahead of #InternationalNursesDay on Monday, #OurMaterTeam celebrated the exceptional work of our @MaterNursing team today.….

RT @TheMaterFoundat: Will you don your blonde hair 👱🏻‍♀️for Women's #Cancercare at @MaterDublin? Join our fab #MarilynMonroe's at the Shore….

To mark #BowelCancerAwareness Month, last year Mater patient Carmel Drohan and #OurMaterTeam consultant colorectal surgeon Prof Ann Brannigan spoke with @answers4cancers. It focuses on Carmel's positive outlook and advancements in treatment. Listen here:

RT @MaterTrauma: We won! The #Mater’s Rock Wing was awarded the The Healthcare Project of the Year at last night’s #IrishBuildingandDesign….

RT @MaterHSCPs: What a lovely story on the wonderful supports offered by our multi-disciplinary #PsychoOncology team here ⁦@MaterCancer⁩ ⁦@….

To achieve our National Cancer Strategy target, to be within the top 25% of EU countries for five year survival rate for all cancers by 2026, we need to focus on advanced and metastatic cancer care. The five-year survival rate for metastatic cancer in Ireland is only 10%.

2/2 In October 2023, a landmark study highlighted the multidisciplinary surgical approach implemented by @donalb5, and gynaecological oncology experts at the #Mater improved the 3-year survival rate for women with advanced ovarian cancer by 70%.

1/2 This month is #OvarianCancerAwarenessMonth. The #Mater is home to one of the largest gynaecological oncology departments in Ireland and offers innovative treatments to patients diagnosed with ovarian cancer.

Receiving a diagnosis of an advanced cancer is no longer a hopeless situation.

Breakthroughs in treatment options and surgeries over the past decade now mean that advanced cancer can be treated; the life and especially the quality of life, of a patient can be improved significantly, and even, on occasion, the patient can be cured completely.

RT @MaterTrauma: On International Women's Week, we celebrate the remarkable women who make up almost three quarters of our workforce at the….

RT @MaterTrauma: Stuart Haxell and Prof David Keegan were on @TodaywithClaire discussing a new development for the treatment of inherited o….

#DYK The five-year survival rate for metastatic cancer in Ireland is only 10%? We need to improve our management of advanced and metastatic cancer through dedicated, specialised services.

RT @TheMaterFoundat: Today is #WorldCancerDay🎗️This year's awareness theme is #unitedbyunique recognising that behind every diagnosis lies….

Today on #WorldCancerDay, #OurMaterTeam reflects on our patients, families and staff who are touched by cancer. As a designated cancer centre, the #Mater is at the forefront of cancer care, and is committed to pushing the boundaries in the management of advanced cancer.

Great to see our nurses and @MaterCancer team getting recognition for their brilliant work in Róisín Ingle's recent @TheIrishTimes article.

RT @ThePillarDublin: 🎯 Advance your practice with the ESHG Precision Medicine Hybrid Workshop 2025!.📅 9th–11th April 2025.📍 The Pillar Cent….